Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors

George D. Demetri, Yanfeng Wang, Elisabeth Wehrle, Amy Racine, Zariana Nikolova, Charles D. Blanke, Heikki Joensuu, Margaret Von Mehren

Research output: Contribution to journalArticlepeer-review

341 Scopus citations

Fingerprint

Dive into the research topics of 'Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences